Barclays
PAVM icon

Barclays’s PAVmed PAVM Stock Holding History

Barclays’s Portfolio PAVM Stock Details PAVM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-2
Closed -$29 – 5560
2025
Q3 		$29 Buy
+2
New +$30 ﹤0.01% 5343
2023
Q1 		– Sell
-18
Closed -$3.84K – 5284
2022
Q4 		$3.84K Hold
18
– – ﹤0.01% 5036
2022
Q3 		$7K Hold
18
– – ﹤0.01% 4423
2022
Q2 		$7K Sell
18
-26
-59% -$12.6K ﹤0.01% 4721
2022
Q1 		$27K Sell
44
-170
-79% -$126K ﹤0.01% 4341
2021
Q4 		$237K Buy
214
+106
+98% +$230K ﹤0.01% 3503
2021
Q3 		$415K Buy
108
+61
+130% +$192K ﹤0.01% 3281
2021
Q2 		$137K Sell
47
-69
-59% -$163K ﹤0.01% 3717
2021
Q1 		$232K Buy
116
+89
+330% +$134K ﹤0.01% 3637
2020
Q4 		$26K Sell
27
-10
-27% -$8.55K ﹤0.01% 4625
2020
Q3 		$29K Sell
37
-7
-16% -$6.23K ﹤0.01% 4818
2020
Q2 		$42K Buy
+44
New +$44K ﹤0.01% 5003
2020
Q1 		– Hold
0
– – – 6381
2019
Q4 		– Hold
0
– – – 6692

Other funds holding PAVM

First Manhattan
First Manhattan New York $36.1B AUM 11.5% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return
CAPTRUST Financial Advisors
CAPTRUST Financial Advisors Raleigh, North Carolina $57.3B AUM 18.32% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

Barclays's PAVM Position: Q4 2025 in Review

Barclays sold out of PAVmed (PAVM) in Q4 2025, closing a stake of 2 shares — an estimated $29 sold.

Barclays first reported a position in PAVM in Q2 2020 and held it in 12 quarters. The position peaked at $415K in Q3 2021. 28 funds tracked by Wall St. Rank hold PAVM as of Q4 2025.

  • Barclays reported no remaining PAVmed position as of Q4 2025 after selling out during the quarter.
  • Barclays sold 2 PAVmed shares in Q4 2025, an estimated $29.
  • Barclays first reported a position in PAVmed in Q2 2020 and held it in 12 quarters.
  • Barclays's PAVmed position peaked at $415K in Q3 2021.
  • 28 funds tracked by Wall St. Rank held PAVmed as of Q4 2025.

Based on Barclays's 13F filing for Q4 2025, filed 13 Feb 2026.